[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357452-105":59,"doc-detail-357452-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-the-d93-cryptic-collagen-epitope-alters-integrin-21-dependent-cellular-migration-and-collagen-remodeling-in-metastatic-breast-cancer","Targeting the D93 cryptic collagen epitope alters integrin α2β1-dependent cellular migration and collagen remodeling in metastatic breast cancer","","Targeting tumor-associated extracellular matrix (ECM) features a promising breast cancer therapy direction by exploiting cryptic collagen epitope exposure during collagen remodeling. In 3D human metastatic breast cancer spheroids generated from MDA-MB-231 and MCF10CA1a (M4) cells embedded in collagen type I hydrogels, monoclonal antibody (mAb) D93 reduced migration into collagen type I, likely via integrin α2β1. Two-photon microscopy showed tumor-driven exposure of D93 sites and altered collagen architecture at fiber and fibril levels, with cell-line specific remodeling and migration effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-the-d93-cryptic-collagen-epitope-alters-integrin-21-dependent-cellular-migration-and-collagen-remodeling-in-metastatic-breast-cancer/357452/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-the-d93-cryptic-collagen-epitope-alters-integrin-21-dependent-cellular-migration-and-collagen-remodeling-in-metastatic-breast-cancer/357452.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What therapeutic concept motivates targeting the D93 cryptic collagen epitope?","Question",{"text":112,"@type":113},"Collagen remodeling in the tumor ECM can expose cryptic collagen epitope sites that antibodies may recognize selectively, offering a targeted ECM-based therapy strategy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does mAb D93 affect breast cancer cell migration in collagen type I?",{"text":117,"@type":113},"mAb D93 reduces cellular migration into collagen type I hydrogels, with the effect likely mediated by integrin α2β1.",{"name":119,"@type":110,"acceptedAnswer":120},"What did two-photon microscopy reveal after D93 treatment?",{"text":121,"@type":113},"Breast cancer cells drive exposure of D93 sites and alter collagen architecture at both fiber and fibril levels, with differences between MDA-MB-231 and M4 spheroid models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357452,1790813557,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTargeting the D93 cryptic collagen epitope alters integrin α2β1-dependent cellular migration and collagen remodeling in metastatic breast cancer  \nJordan N. Miner1,2,3, Christopher L. Emmerling4, Joshua D. Hamilton1,2,3, Joseph Raite4, Zoe Vittum1, Peter C. Brooks2,5, Andre Khalil1,2,3 & Karissa Tilbury1,2􀀍  \nTargeting the tumor-associated extracellular matrix (ECM) offers a promising strategy for breast cancer therapy. During cancer progression, collagen remodeling within the ECM exposes cryptic collagen epitope sites that antibodies can selectively recognize. Here, we investigate the therapeutic potential of targeting the D93 cryptic collagen epitope in 3D human metastatic breast cancer spheroids derived from MDA-MB-231 and MCF10CA1a (M4) cell lines embedded in collagen type I hydrogels. Treatment with monoclonal antibody (mAb) D93 reduced cellular migration into collagen type I hydrogels, an effect likely mediated by integrin α2β1. Two-photon microscopy further revealed that breast cancer cells drive the exposure of D93 sites and alter collagen architecture at both the fiber and fibril levels. Interestingly, collagen remodeling was altered more in the MDA-MB-231 spheroid models whereas the reduction in cellular migration was more pronounced in the M4 spheroid models, indicating a cell-line specific response to mAb D93. Together, these findings suggest that mAb D93 may inhibit integrin α2β1-dependent metastatic migration in breast cancer.  \nKeywords Breast cancer, Spheroids, Migration, Integrin, Second harmonic generation (SHG) microscopy, Collagen  \nBreast cancer is a heterogeneous disease and thus advancements in precision medicine is essential for optimal patient treatment1. This is especially true for triple negative breast cancer (TNBC) which is negative for the estrogen receptor (ER), the progesterone receptor (PR) and human epidermal growth factor 2 (HER2)1–3. Due to the lack of these receptors, TNBC is typically treated with chemotherapy and has a poor clinical prognosis3. While some treatments target cells directly, others target the extracellular matrix (ECM) surrounding the tumor1,4. The ECM plays a critical role in cancer growth and metastasis4. However, targeting the ECM has seen limited success in the past due to its heterogeneity, complexity, and dual role in promoting and inhibiting tumorigenesis5. For example, a recent phase III trial did not support the clinical development of PEGPH20 for use in pancreatic cancer patients which degrades tumor hyaluronan6. Furthermore, no clinical benefit was seen with simtuzumab, a humanized anti-lysyl oxidase-like 2 (LOXL2) antibody for fibrosis patients7. Even with these setbacks, ECM-targeting strategies still remain promising for cancer treatments given proper refinement5,8–10. The ECM is primarily composed of collagen, a triple helical protein that not only provides mechanical support11, but also mediates signaling which impacts cellular behaviors including adhesion, proliferation, and migration4. During cancer progression, collagen is remodeled to expose cryptic collagen epitope sites4. One such site, HU177, has been shown to influence cellular migration in cancers such as melanoma12 and ovarian cancer13. Additionally, the monoclonal antibody (mAb) targeting the HU177 site selectively binds to denatured collagen which minimizes off-target effects4, 14, 15. Although the exact mechanism by which the HU177 site becomes exposed remains unclear, matrix metalloproteinases (MMPs)4, 16–19 and cathepsins4,20,21 have been shown to degrade collagen through proteolytic processes. Furthermore, other studies have suggested that mechanical  \n1Department of Chemical and Biomedical Engineering, University of Maine, Orono, ME, USA. 2Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME, USA. 3CompuMAINE Laboratory, University of Maine, Orono, ME, USA. 4Department of Chemistr","cbCaipz9uy1aIuhE","https://ap.wps.com/l/cbCaipz9uy1aIuhE","pdf",4689049,18,"English","# Background\n## Triple-negative breast cancer and ECM targeting\n## Cryptic collagen epitopes and HU177/D93 rationale\n# Experimental approach\n## 3D metastatic breast cancer spheroids and collagen hydrogels\n## Antibody treatment and migration assessment\n## Two-photon microscopy and collagen architecture analysis\n# Findings and implications\n## Integrin α2β1-mediated migration reduction\n## Cell-line specific responses\n## Therapeutic relevance for metastatic migration","[{\"question\":\"What therapeutic concept motivates targeting the D93 cryptic collagen epitope?\",\"answer\":\"Collagen remodeling in the tumor ECM can expose cryptic collagen epitope sites that antibodies may recognize selectively, offering a targeted ECM-based therapy strategy.\"},{\"question\":\"How does mAb D93 affect breast cancer cell migration in collagen type I?\",\"answer\":\"mAb D93 reduces cellular migration into collagen type I hydrogels, with the effect likely mediated by integrin α2β1.\"},{\"question\":\"What did two-photon microscopy reveal after D93 treatment?\",\"answer\":\"Breast cancer cells drive exposure of D93 sites and alter collagen architecture at both fiber and fibril levels, with differences between MDA-MB-231 and M4 spheroid models.\"}]","Targeting the D93 cryptic collagen epitope alters integrin α2β1-dependent cellular migration and collagen remodeling in metastatic breast cancer | PDF",1790130050,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c51eae92ab277e3b53ba9837b07ee6a6.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82fac9ff9809fc034c01c9390b4cf86a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd21c0ced4bc7015e6a7210fbeaf71ae.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f499c3dae94213278ad589054b36796.webp",980,1287]